Rezolute (RZLT) Accumulated Depreciation & Amortization (2014 - 2025)
Rezolute's (RZLT) quarterly Accumulated Depreciation & Amortization came in at $138000.0 in Q2 2025, up 28.97% year-on-year from $107000.0 in Q2 2024, and up 28.97% quarter-over-quarter from $107000.0 in Q2 2024.
Rezolute (RZLT) Accumulated Depreciation & Amortization (2014 - 2025) Analysis & Trends
Rezolute has disclosed Accumulated Depreciation & Amortization across 12 years of filings, most recently posting $138000.0 for Q2 2025.
- Accumulated Depreciation & Amortization for Q2 2025 came in at $138000.0, up 28.97% year-over-year; the trailing twelve-month figure through Jun 2025 was $138000.0 (up 28.97% YoY), and the FY2025 annual result was $138000.0, up 28.97% from the prior year.
- Accumulated Depreciation & Amortization came in at $138000.0 for Q2 2025 at Rezolute, up from $107000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $138000.0 in Q2 2025 to a low of $27000.0 in Q2 2021.
- The 5-year median for Accumulated Depreciation & Amortization is $71000.0 (2023), against an average of $76600.0.
- Across the five-year window, Accumulated Depreciation & Amortization surged 92.86% in 2021 and increased 28.97% in 2025, its largest moves.
- Rezolute's Accumulated Depreciation & Amortization stood at $27000.0 in 2021, then surged by 48.15% to $40000.0 in 2022, then soared by 77.5% to $71000.0 in 2023, then surged by 50.7% to $107000.0 in 2024, then increased by 28.97% to $138000.0 in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $138000.0 (Q2 2025), $107000.0 (Q2 2024), and $71000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Rezolute | 425.23 Mn | 425.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 138,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2023 | 71,000.00 |
| Jun 30, 2023 | 71,000.00 |
| Jun 30, 2022 | 40,000.00 |
| Jun 30, 2022 | 40,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Jun 30, 2021 | 27,000.00 |
| Jun 30, 2020 | 14,000.00 |
| Jun 30, 2020 | 14,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 44,811.00 |
| Mar 31, 2019 | 44,811.00 |
| Dec 31, 2018 | 12,664.00 |
| Dec 31, 2018 | 12,664.00 |
| Sep 30, 2018 | 443,843.00 |
| Sep 30, 2018 | 443,843.00 |